Lionco Pharmaceutical Group Co.,Ltd. Stock: price and insider trades · China
灵康药业
Lionco Pharmaceutical Group Co.,Ltd.: what insiders have been doing
Insider filings for Lionco Pharmaceutical Group Co.,Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 19 July 2021. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 467,500 shares100.0% of flowA股XSHGSSE:173000004580414140
1 of 1 declaration
About Lionco Pharmaceutical Group Co.,Ltd.
灵康药业 is a company operating in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of innovative medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
